(Q44575015)

4 December 2017

Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure (English)

1 reference

4 December 2017

1 reference

1 reference

3

Anthony S Wierzbicki

1 reference

4 December 2017

Rashed Bakri

1

1 reference

4 December 2017

Joe Wang

series ordinal

2

1 reference

4 December 2017

David Goldsmith

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

International Journal of Cardiology

4 December 2017

1 reference

4 December 2017

91

1 reference

4 December 2017

1

1 reference

4 December 2017

107-109

1 reference

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900581-8

7 January 2021

Withdrawal of cerivastatin from the world market

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900581-8

7 January 2021

Cerivastatin-induced rhabdomyolysis: 11 case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900581-8

7 January 2021

Cerivastatin and reports of fatal rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900581-8

7 January 2021

Another report of acute rhabdomyolysis following cerivastatin monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900581-8

7 January 2021

10.1016/S0167-5273(02)00581-8

Identifiers

DOI

1 reference

4 December 2017

1 reference